Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL295945 | 0.89 | — | — | |
| SCHEMBL16892662 | 0.84 | — | — | |
| SCHEMBL395345 | 0.80 | — | — | |
| SCHEMBL1194926 | 0.79 | — | — | |
| SCHEMBL5697648 | 0.79 | OPRM1 (0.32) | — | |
| SCHEMBL395264 | 0.75 | — | — | |
| SCHEMBL16892646 | 0.75 | — | — | |
| SCHEMBL1854085 | 0.73 | — | — | |
| SCHEMBL580060 | 0.72 | — | — | |
| SCHEMBL22444553 | 0.71 | CA1 (0.34) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1937697-B1 | METHOD FOR PRODUCTION OF ISOCYANATOSILANES | MOMENTIVE PERFORMANCE MAT INC (US) | 2013-10-16 | — | — | EP | claimed |
| US-7825243-B2 | Process for the production of isocyanatosilane and silylisocyanurate | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2010-11-02 | — | — | US | claimed |
| EP-1937697-A2 | METHOD FOR PRODUCTION OF ISOCYANATOSILANES | Momentive Performance Materials Inc. (US) | 2008-07-02 | — | — | EP | claimed |
| WO-2007037817-A2 | METHOD FOR PRODUCTION OF ISOCYANATOSILANES | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2007-04-05 | — | — | WO | claimed |
| US-20060276644-A1 | Process for the production of isocyanatosilane and silylisocyanurate | GENERAL ELECTRIC COMPANY | 2006-12-07 | — | — | US | claimed |
| US-7060849-B1 | Method for production of isocyanatosilanes | GENERAL ELECTRIC COMPANY (US) | 2006-06-13 | — | — | US | claimed |
| EP-1937697-B1 | METHOD FOR PRODUCTION OF ISOCYANATOSILANES | MOMENTIVE PERFORMANCE MAT INC (US) | 2013-10-16 | — | — | EP | disclosed |
| EP-1937697-A2 | METHOD FOR PRODUCTION OF ISOCYANATOSILANES | Momentive Performance Materials Inc. (US) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007037817-A2 | METHOD FOR PRODUCTION OF ISOCYANATOSILANES | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2007-04-05 | — | — | WO | disclosed |
| US-7060849-B1 | Method for production of isocyanatosilanes | GENERAL ELECTRIC COMPANY (US) | 2006-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276644-A1 | Process for the production of isocyanatosilane and silylisocyanurate | SI, TST, PCMT1 | CA1 160/4885CA2 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.